Investors' expectations of limited future growth may be caus...
Investors' expectations of limited future growth may be causing the low P/S ratio. These conditions form a barrier for the share price unless improved. Consider other vital risk factors before investing in Capricor Therapeutics.
Revenues Working Against Capricor Therapeutics, Inc.'s (NASDAQ:CAPR) Share Price Following 25% Dive
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment